BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 1345491)

  • 1. Blood products.
    Hutchinson RJ
    Semin Pediatr Surg; 1992 Aug; 1(3):231-41. PubMed ID: 1345491
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pediatric transfusion: considerations by age and blood component.
    Glassman AB
    South Med J; 1982 Jun; 75(6):722-5. PubMed ID: 6806910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood component therapy.
    Fasano R; Luban NL
    Pediatr Clin North Am; 2008 Apr; 55(2):421-45, ix. PubMed ID: 18381094
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Transfusion of blood and products derived from blood].
    Wautier JL
    Rev Prat; 1999 Feb; 49(4):409-13. PubMed ID: 10319693
    [No Abstract]   [Full Text] [Related]  

  • 5. [Indications for labile blood products].
    Jeanne M; Rasonglès P
    Rev Prat; 2001 Jun; 51(12):1318-27. PubMed ID: 11503505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Indications for use of labile blood products and the physiology of blood transfusion in medicine. The French Agency for the Health Safety of Health Products].
    Gouëzec H; Jego P; Bétrémieux P; Nimubona S; Grulois I
    Transfus Clin Biol; 2005 Jun; 12(2):169-76. PubMed ID: 15894502
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transfusion medicine and surgical practice.
    Valeri CR
    Bull Am Coll Surg; 1993 Sep; 78(9):19-24. PubMed ID: 10171511
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemostasis and transfusion aspects of blood and plasma product safety].
    Seyfert UT; Mörsdorf S; Mertzlufft F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1999 Aug; 34(8):488-92. PubMed ID: 10494368
    [No Abstract]   [Full Text] [Related]  

  • 9. [Risks of infection caused by blood and blood products with reference to the so-called AIDS scandal].
    Kretschmer V
    Infusionsther Transfusionsmed; 1993 Dec; 20(6):286-90. PubMed ID: 8142734
    [No Abstract]   [Full Text] [Related]  

  • 10. Pediatric hemostasis and use of plasma components.
    Goldenberg NA; Manco-Johnson MJ
    Best Pract Res Clin Haematol; 2006; 19(1):143-55. PubMed ID: 16377547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Update on transfusion medicine.
    Shander A; Goodnough LT
    Pharmacotherapy; 2007 Sep; 27(9 Pt 2):57S-68S. PubMed ID: 17723109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term survival after blood transfusion: a population based study in the North of England.
    Wallis JP; Wells AW; Matthews JN; Chapman CE
    Transfusion; 2004 Jul; 44(7):1025-32. PubMed ID: 15225243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The risk of substitution therapy with blood and blood products].
    Baumgarten R
    Z Arztl Fortbild (Jena); 1994 Jan; 88(1):3-4. PubMed ID: 8154136
    [No Abstract]   [Full Text] [Related]  

  • 14. An update on the assessment and management of the risk of transmission of variant Creutzfeldt-Jakob disease by blood and plasma products.
    Turner ML; Ludlam CA
    Br J Haematol; 2009 Jan; 144(1):14-23. PubMed ID: 18950452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Guidelines on gamma irradiation of blood components for the prevention of transfusion-associated graft-versus-host disease. BCSH Blood Transfusion Task Force.
    Transfus Med; 1996 Sep; 6(3):261-71. PubMed ID: 8885157
    [No Abstract]   [Full Text] [Related]  

  • 16. Diagnosis and procedure-specific survival among transfusion of recipients in 1993 and 2000, Orebro County, Sweden.
    Tynell E; Norda R; Montgomery SM; Björkman A
    Vox Sang; 2005 Apr; 88(3):181-8. PubMed ID: 15787728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative pediatric blood transfusion therapy: a review of common issues. Part I: hematologic and physiologic differences from adults; metabolic and infectious risks.
    Barcelona SL; Thompson AA; Coté CJ
    Paediatr Anaesth; 2005 Sep; 15(9):716-26. PubMed ID: 16101701
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Warm fresh whole blood transfusion for severe hemorrhage: U.S. military and potential civilian applications.
    Spinella PC
    Crit Care Med; 2008 Jul; 36(7 Suppl):S340-5. PubMed ID: 18594261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blood transfusions in children: a multi-institutional analysis of practices and complications.
    Slonim AD; Joseph JG; Turenne WM; Sharangpani A; Luban NL
    Transfusion; 2008 Jan; 48(1):73-80. PubMed ID: 17894792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The natural history of hepatitis A: the potential for transmission by transfusion of blood or blood products.
    Lemon SM
    Vox Sang; 1994; 67 Suppl 4():19-23; discussion 24-6. PubMed ID: 7831865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.